NABIP challenges CMS over ACA broker freeze before open enrollment
The National Association of Benefits and Insurance Professionals has filed suit against CMS over a moratorium that blocks new brokers from registering in the Affordable Care Act marketplaces ahead of open enrollment. The trade group says the policy reaches roughly 19,000 brokers and agents and shuts out legitimate professionals who have not been accused of wrongdoing.
The dispute lands at the intersection of marketplace integrity and consumer access. CMS has cast the move as part of a broader fraud crackdown, while NABIP argues the agency has swept too broadly and imposed a sweeping restriction without individualized evidence against the affected brokers.
A single regulatory decision now determines who can help millions of consumers navigate coverage choices.
CMS frames the restriction as a fraud-control measure
CMS unveiled the moratorium in late September as part of a wider effort to curb fraud, waste and abuse in the ACA marketplaces. The agency has also said it will terminate more than 200 agents and brokers who failed to comply with marketplace standards. Its central concern is not abstract: improper enrollments have become a recurring enforcement target, with officials warning that some consumers have been enrolled in plans without their knowledge or even after death.
The agency has also said new brokers and agents were disproportionately responsible for inappropriate enrollments and other behaviors considered high risk for fraud. That rationale gives the moratorium a defensive posture. In CMS’ view, limiting fresh registrations is a fast way to reduce the number of bad actors entering the system at a time when marketplace oversight has become more aggressive.
The same logic, however, is exactly what NABIP is attacking in court.
NABIP says the rule sweeps in legitimate professionals
In its complaint, NABIP argues that the moratorium violates both the Administrative Procedure Act and the Affordable Care Act. The organization says the regulation is arbitrary, capricious and unsupported by sufficient evidence. Its central objection is narrow and concrete: CMS is excluding thousands of legitimate agents based solely on whether they registered last year, not on any individualized finding of fraud or misconduct.
That approach, NABIP says, harms brokers who have played a central role in helping consumers select coverage that fits their needs. The group also warns that restricting broker participation reduces access to professional assistance at a moment when consumers need support to compare plans, verify eligibility and navigate open enrollment decisions.
Mychal Walker, NABIP’s president, said the association does not dispute that fraud exists and has already raised those concerns with CMS. The fight, he said, is over the remedy. NABIP wants the agency to target fraud where it occurs, strengthen system security and hold bad actors accountable without cutting off legitimate professionals from the marketplace.
Open enrollment turns a legal fight into an access question
The practical stakes are immediate. Brokers and agents are often the first line of support for consumers sorting through deductibles, networks, subsidies and coverage changes during open enrollment. When that network shrinks, the burden shifts toward consumers who may already struggle with plan literacy, digital enrollment systems and eligibility rules that change from year to year.
For CMS, the moratorium reflects a hard-edged enforcement strategy: fewer registrations could mean fewer opportunities for fraudulent actors to exploit marketplace weaknesses. For brokers, the same policy reads as collective punishment. The tension is not merely procedural. It goes to whether the federal government can temporarily bar an entire class of marketplace participants to reduce abuse, even when many in that class have no allegation attached to their names.
The lawsuit puts pressure on the agency to justify the scope of its response. Under the Administrative Procedure Act, broad regulatory actions often face scrutiny when the agency record does not clearly support the chosen remedy or when less restrictive alternatives appear available. NABIP is signaling that CMS had other tools at its disposal, including tighter monitoring, stronger verification systems and more targeted enforcement against specific offenders.
Fraud enforcement and market access are now on a collision course
CMS has been escalating its scrutiny of duplicate and improper enrollments across federal coverage programs. Earlier this week, the agency said it would purge 189,000 enrollees who were listed as enrolled in both ACA plans and other coverage, including Medicaid or Medicare. That step reflects a broader willingness to intervene aggressively when the marketplace shows signs of overlap, duplication or potential abuse.
In that environment, the broker moratorium is part of a larger enforcement architecture rather than an isolated policy choice. CMS appears to be treating marketplace registration controls as a front-end defense against fraudulent enrollments, while NABIP is arguing that the agency is treating every new broker as a risk signal. The difference matters because broker participation is not peripheral to the marketplaces; it is embedded in how consumers are steered into plans, how applications are completed and how coverage problems are corrected after enrollment.
This is where the policy burden becomes visible in daily operations. If new brokers are kept out, consumers lose one category of assistance. If oversight is weakened, fraudulent enrollments can erode trust in the marketplaces and complicate subsidy administration. CMS is trying to contain one problem without creating another. Courts will now weigh whether the balance is lawful.
The case tests how far CMS can go to police ACA enrollment
The lawsuit is likely to turn on administrative law as much as on health policy. NABIP has framed the moratorium as an overreach that lacks adequate evidence and fails to distinguish between fraudulent actors and compliant professionals. CMS, by contrast, will need to defend the moratorium as a reasonable response to documented marketplace abuse and as a proportionate step in a fraud prevention campaign.
At stake is more than a registration rule. If the court upholds the moratorium, CMS could emerge with wider latitude to impose broad enrollment restrictions in the name of marketplace integrity. If the challenge succeeds, the agency may be forced toward more targeted oversight and narrower sanctions tied to individual conduct.
The case arrives while CMS is already under pressure to demonstrate that its anti-fraud efforts are precise enough to protect both program integrity and access to coverage. The next phase will show whether the government can persuade a court that a sweeping broker freeze is a lawful response to marketplace abuse, or whether the rule goes too far by treating status as a proxy for risk.